Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Diffuse large B-cell lymphoma: the history, current view and new perspectives

P Flodr, P Latalova, M Tichy, Z Kubova, T Papajik, M Svachova, K Vrzalikova, L Radova, M Jarosova, P Murray

. 2014 ; 61 (5) : 491-504.

Jazyk angličtina Země Slovensko

Perzistentní odkaz   https://www.medvik.cz/link/bmc17011089

Grantová podpora
NT11103 MZ0 CEP - Centrální evidence projektů

The basic principles of lymphoma classification(s) in general have been widely evolving in acourse of decades of years wiht the use of contemporary resources and recent cutting edges in hematooncology on aclinical, morphological and molecular level bring new possibilities not only in improvements of diagnostic and prognostic algorithms and also bear new opportunities in so called targeted and tailored strategies of lymphoma therapy. The pathogenesis and biologic behavior of lymphoproliferations and even lymphomas should be studied in acontext of lymphocytic and (neoplastic) lymphoid stage and chronologic development. In acurrent more complex insight into lymphoproliferations we would like to describe huge heterogeneity of diffuse large B-cell lymphoma in relationship to mandatory WHO classification since 2008 and the next development of knowledge in this field with potential new influence on an advancement of both classification and therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17011089
003      
CZ-PrNML
005      
20191014110356.0
007      
ta
008      
170327s2014 xo f 000 0|eng||
009      
AR
024    7_
$a 10.4149/neo_2014_062 $2 doi
035    __
$a (PubMed)25030433
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xo
100    1_
$a Flodr, Patrik, $d 1975- $7 nlk20030127444 $u Dept. of Clinical and Molecular Pathology, Faculty of Medicine and dentistry, Palacký University, Olomouc, Czech Republic; School of Cancer Science, University of Birmingham, UK
245    10
$a Diffuse large B-cell lymphoma: the history, current view and new perspectives / $c P Flodr, P Latalova, M Tichy, Z Kubova, T Papajik, M Svachova, K Vrzalikova, L Radova, M Jarosova, P Murray
520    9_
$a The basic principles of lymphoma classification(s) in general have been widely evolving in acourse of decades of years wiht the use of contemporary resources and recent cutting edges in hematooncology on aclinical, morphological and molecular level bring new possibilities not only in improvements of diagnostic and prognostic algorithms and also bear new opportunities in so called targeted and tailored strategies of lymphoma therapy. The pathogenesis and biologic behavior of lymphoproliferations and even lymphomas should be studied in acontext of lymphocytic and (neoplastic) lymphoid stage and chronologic development. In acurrent more complex insight into lymphoproliferations we would like to describe huge heterogeneity of diffuse large B-cell lymphoma in relationship to mandatory WHO classification since 2008 and the next development of knowledge in this field with potential new influence on an advancement of both classification and therapy.
590    __
$a bohemika - dle Pubmed
650    02
$a lidé $7 D006801
650    12
$a difúzní velkobuněčný B-lymfom $x klasifikace $7 D016403
650    02
$a difúzní velkobuněčný B-lymfom $x patologie $7 D016403
650    02
$a difúzní velkobuněčný B-lymfom $x terapie $7 D016403
650    02
$a prognóza $7 D011379
700    1_
$a Flodrová, Pavla $u Dept. of Clinical and Molecular Pathology, Faculty of Medicine and dentistry, Palacký University, Olomouc, Czech Republic $7 xx0139492
700    1_
$a Tichý, Martin, $d 1943- $7 nlk20030127453 $u Dept. of Clinical and Molecular Pathology, Faculty of Medicine and dentistry, Palacký University, Olomouc, Czech Republic
700    1_
$a Kubová, Zuzana $7 xx0199107 $u Dept. of Hemato-oncology, Faculty Hospital Olomouc, Czech Republic
700    1_
$a Papajík, Tomáš, $d 1967- $7 xx0060566 $u Dept. of Hemato-oncology, Faculty Hospital Olomouc, Czech Republic
700    1_
$a Šváchová, Michaela $7 xx0103855 $u Dept. of Clinical and Molecular Pathology, Faculty of Medicine and dentistry, Palacký University, Olomouc, Czech Republic
700    1_
$a Vrzalíková, Kateřina $7 _AN059363 $u Dept. of Clinical and Molecular Pathology, Faculty of Medicine and dentistry, Palacký University, Olomouc, Czech Republic; School of Cancer Science, University of Birmingham, UK; Institute of Malecular and Translation Medicine, Faculty of Medicine and dentistry, Palacký University, Olomouc, Czech Republic
700    1_
$a Radová, Lenka $7 xx0092752 $u Institute of Malecular and Translation Medicine, Faculty of Medicine and dentistry, Palacký University, Olomouc, Czech Republic
700    1_
$a Jarošová, Marie, $d 1950- $7 xx0053403 $u Dept. of Hemato-oncology, Faculty Hospital Olomouc, Czech Republic
700    1_
$a Murray, Paul G. $7 xx0165205 $u School of Cancer Science, University of Birmingham, UK; Institute of Malecular and Translation Medicine, Faculty of Medicine and dentistry, Palacký University, Olomouc, Czech Republic
773    0_
$t Neoplasma $x 0028-2685 $g Roč. 61, č. 5 (2014), s. 491-504 $p Neoplasma $w MED00003470
910    __
$a ABA008 $b A 1194 $y 4 $z 0
990    __
$a 20170327120319 $b ABA008
991    __
$a 20191014110820 $b ABA008
999    __
$a ok $b bmc $g 1196053 $s 971830
BAS    __
$a 3
BMC    __
$a 2014 $b 61 $c 5 $d 491-504 $x MED00003470 $i 0028-2685 $m Neoplasma
GRA    __
$a NT11103 $p MZ0
LZP    __
$a NLK 2017-B/lp

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...